Study demonstrates the viability and value of RNA sequencing from formalin fixed samples in gaining a deeper understanding of patient...
Nanthealth Inc., Nantomics LLC and Immunitybio Inc., all of Culver City, Calif., developed image-based risk models for tumors using images from 82 pancreatic...
NantHealth, ImmunityBio and NantOmics Presented Results at the 2020 AACR Virtual Special Conference: Pancreatic Cancer Culver City, CA – October...
Study Published In Breast Cancer Research Shows How Deep-Learning Of Over 650 Breast Cancer Digital Pathology Images And Omics Data...
Findings Presented at the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium Orlando, FL and Culver City, CA – February 19, 2020 –...
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA...
Patients and physicians can now access active clinical trials for various cancer types including lung, breast, leukemia and more through...
Randomized (TASTE) Trial In Early Stage Non-Small Cell Lung Cancer Trial, Demonstrates That GPS Proteomics Analysis Could Predict Tumor Response...
The NantOmics Cancer Genome Browser platform on the BlackBerry Passport enables deep, interactive reporting on genomics data for physicians and...